Merlin Capital’s Intellia Therapeutics NTLA Stock Holding History

Merlin Capital’s Portfolio NTLA Stock Details NTLA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$488K	Sell
2023 Q4	$818K	Buy
2023 Q3	$586K	Buy
2023 Q2	$719K	Buy
2023 Q1	$470K	Buy
2022 Q4	$429K	Buy
2022 Q3	$652K	Sell
2022 Q2	$630K	Buy
2022 Q1	$841K	Buy
2021 Q4	$775K	Buy